Bank of New York Mellon’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-21,058
| Closed | -$194K | – | 4591 |
|
|
2021
Q2 | $194K | Sell |
21,058
-109,653
| -84% | -$638K | ﹤0.01% | 4109 |
|
|
2021
Q1 | $650K | Sell |
130,711
-119
| -0.1% | -$575 | ﹤0.01% | 3550 |
|
|
2020
Q4 | $564K | Sell |
130,830
-7,172
| -5% | -$29.2K | ﹤0.01% | 3562 |
|
|
2020
Q3 | $592K | Sell |
138,002
-9,972
| -7% | -$41.7K | ﹤0.01% | 3408 |
|
|
2020
Q2 | $665K | Buy |
147,974
+16,904
| +13% | +$75.5K | ﹤0.01% | 3324 |
|
|
2020
Q1 | $525K | Buy |
131,070
+17,323
| +15% | +$147K | ﹤0.01% | 3339 |
|
|
2019
Q4 | $965K | Buy |
113,747
+3,684
| +3% | +$28.7K | ﹤0.01% | 3265 |
|
|
2019
Q3 | $754K | Sell |
110,063
-2,396
| -2% | -$17.6K | ﹤0.01% | 3325 |
|
|
2019
Q2 | $936K | Buy |
112,459
+1,545
| +1% | +$13.3K | ﹤0.01% | 3260 |
|
|
2019
Q1 | $1.02M | Buy |
110,914
+9,545
| +9% | +$96.9K | ﹤0.01% | 3167 |
|
|
2018
Q4 | $1.11M | Buy |
101,369
+10,522
| +12% | +$133K | ﹤0.01% | 3049 |
|
|
2018
Q3 | $1.27M | Buy |
90,847
+17,798
| +24% | +$241K | ﹤0.01% | 3124 |
|
|
2018
Q2 | $778K | Sell |
73,049
-15,114
| -17% | -$147K | ﹤0.01% | 3391 |
|
|
2018
Q1 | $762K | Buy |
88,163
+4,620
| +6% | +$40.5K | ﹤0.01% | 3353 |
|
|
2017
Q4 | $789K | Buy |
83,543
+8,995
| +12% | +$70.3K | ﹤0.01% | 3380 |
|
|
2017
Q3 | $586K | Buy |
74,548
+11,081
| +17% | +$83.1K | ﹤0.01% | 3510 |
|
|
2017
Q2 | $546K | Buy |
+63,467
| New | +$455K | ﹤0.01% | 3563 |
|
|
2015
Q2 | – | Sell |
-39,466
| Closed | -$282K | – | 4346 |
|
|
2015
Q1 | $282K | Sell |
39,466
-73
| -0.2% | -$503 | ﹤0.01% | 3800 |
|
|
2014
Q4 | $295K | Sell |
39,539
-716
| -2% | -$6.07K | ﹤0.01% | 3786 |
|
|
2014
Q3 | $372K | Sell |
40,255
-95
| -0.2% | -$1.28K | ﹤0.01% | 3718 |
|
|
2014
Q2 | $753K | Buy |
40,350
+18,413
| +84% | +$313K | ﹤0.01% | 3464 |
|
|
2014
Q1 | $407K | Buy |
+21,937
| New | +$418K | ﹤0.01% | 3646 |
|
Other funds holding KIN
Bank of New York Mellon's KIN Position: Q3 2021 in Review
Bank of New York Mellon sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 21,058 shares — an estimated $194K sold.
Bank of New York Mellon first reported a position in KIN in Q1 2014 and held it in 22 quarters. The position peaked at $1.27M in Q3 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Bank of New York Mellon reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Bank of New York Mellon sold 21,058 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $194K.
- Bank of New York Mellon first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 22 quarters.
- Bank of New York Mellon's Kindred Biosciences, Inc. position peaked at $1.27M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.